These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2703850)

  • 21. Flunarizine and cinnarizine-induced parkinsonism: 25 years of de Melo-Souza's syndrome.
    Teive HA; Munhoz RP; Ferraz HB
    Arq Neuropsiquiatr; 2009 Sep; 67(3B):957. PubMed ID: 19838540
    [No Abstract]   [Full Text] [Related]  

  • 22. Risk of parkinsonism induced by flunarizine or cinnarizine: a population-based study.
    Lin HL; Lin HC; Tseng YF; Chen SC; Hsu CY
    Eur J Clin Pharmacol; 2017 Mar; 73(3):365-371. PubMed ID: 27986997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flunarizine and cinnarizine-induced parkinsonism: a historical and clinical analysis.
    Teive HA; Troiano AR; Germiniani FM; Werneck LC
    Parkinsonism Relat Disord; 2004 Jun; 10(4):243-5. PubMed ID: 15120099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse reactions to cinnarizine.
    Bhatia RS
    J Assoc Physicians India; 1989 Nov; 37(11):733. PubMed ID: 2632552
    [No Abstract]   [Full Text] [Related]  

  • 25. Iatrogenic parkinsonism: the role of flunarizine and cinnarizine.
    Miguel R; Correia AS; Bugalho P
    J Parkinsons Dis; 2014; 4(4):645-9. PubMed ID: 25125483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Side-effects of flunarizine.
    Lancet; 1986 Aug; 2(8504):463-4. PubMed ID: 2874450
    [No Abstract]   [Full Text] [Related]  

  • 27. [Flunarizine and a depressive syndrome].
    Pradalier A; Vincent D; Dry J
    Therapie; 1988; 43(1):60-1. PubMed ID: 3358255
    [No Abstract]   [Full Text] [Related]  

  • 28. Organic depression associated with flunarizine.
    Patten S; Thompson J
    Can J Psychiatry; 1995 Mar; 40(2):111-2. PubMed ID: 7788616
    [No Abstract]   [Full Text] [Related]  

  • 29. Parkinsonism and other movement disorders in outpatients in chronic use of cinnarizine and flunarizine.
    Fabiani G; Pastro PC; Froehner C
    Arq Neuropsiquiatr; 2004 Sep; 62(3B):784-8. PubMed ID: 15476069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium-entry blockers-induced parkinsonism: possible role of inherited susceptibility.
    Negrotti A; Calzetti S; Sasso E
    Neurotoxicology; 1992; 13(1):261-4. PubMed ID: 1508427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-marketing cohort study comparing the safety and efficacy of flunarizine and propranolol in the prophylaxis of migraine.
    Verspeelt J; De Locht P; Amery WK
    Cephalalgia; 1996 Aug; 16(5):328-36; discussion 288. PubMed ID: 8869768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extrapyramidal side effects: a historical perspective.
    Rifkin A
    J Clin Psychiatry; 1987 Sep; 48 Suppl():3-6. PubMed ID: 2887555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extrapyramidal adverse drug reactions associated with trimetazidine: a series of 21 cases.
    Masmoudi K; Masson H; Gras V; Andréjak M
    Fundam Clin Pharmacol; 2012 Apr; 26(2):198-203. PubMed ID: 22044594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Nervous system disorders in workers constantly exposed to manganese].
    Maślanka S
    Pol Tyg Lek; 1984 Sep; 39(39):1293-5. PubMed ID: 6504761
    [No Abstract]   [Full Text] [Related]  

  • 35. Fluoxetine and extrapyramidal side effects.
    Am J Psychiatry; 1989 Oct; 146(10):1352-3. PubMed ID: 2604792
    [No Abstract]   [Full Text] [Related]  

  • 36. Flunarizine in the prevention of classical migraine: a placebo-controlled evaluation.
    Mendenopoulos G; Manafi T; Logothetis I; Bostantjopoulou S
    Cephalalgia; 1985 Mar; 5(1):31-7. PubMed ID: 3886152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Double-blind clinical study: flunarizine versus pizotifen in a single nightly dose in hemicrania patients].
    Cerbo R; Casacchia M; Formisano R; Buzzi MG; Boni B; Feliciani M; Grillo G; Cusimano G; Agnoli A
    Riv Neurol; 1985; 55(2):139-46. PubMed ID: 4012191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Difficulties in neuroleptic treatment of schizophrenic patients].
    Woggon B
    Schweiz Arch Neurol Psychiatr (1985); 1985; 136(1):55-9. PubMed ID: 2579426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flunarizine in common migraine: Italian cooperative trial. II. Long-term follow-up.
    Bono G; Manzoni GC; Martucci N; Baldrati A; Farina S; Cassabgi F; De Carolis P; Nappi G
    Cephalalgia; 1985 May; 5 Suppl 2():155-8. PubMed ID: 3893736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extrapyramidal side-effects of flunarizine.
    De Michele G; Filla A; Coppola N; Mansi D; Brescia Morra ; Buscaino GA
    Acta Neurol (Napoli); 1987 Jun; 9(3):230-3. PubMed ID: 3630796
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.